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Practical experience shows that Leucaena leucocephala has long been used as a medicinal plant. 
The finely ground, crushed, or chewed leaves of this shrub are applied to the wound. This study aimed 
to determine the antibacterial activity of L. leucocephala leaf extract ointment against Staphylococcus 
aureus and Staphylococcus epidermidis. The extract was made by macerating L. leucocephala leaf 
powder in ethanol 70% with 10% concentration. The research samples included seven (7) formulas of 
ointments with various L. leucocephala leaf extract (LLE) concentrations, namely F1 (0%), F2 (5%), 
F3 (10%), F4 (15%), F5 (20%), F6 (25%), and F7(100%). Their antibacterial activities were measured 
from the diameter of the inhibition zone, which was formed because the administered antibiotics 
stopped the growth of S. aureus and S. epidermidis placed in Nutrient Agar medium. Gentamicin 
Sulfate ointment and Oxytetracycline HCl ointment were used as positive controls. The results showed 
that LLE inhibited the growth of S. aureus and S. epidermidis when prepared at concentrations of at 
least 20% (F5) and 25% (F6), respectively. The difference between the antibacterial activities of LLE 
100% and Gentamicin Sulfate ointment was not significant. The capacities of LLE to prevent the 
growth of S. aureus and S. epidermidis were lower than Oxytetracycline ointment. These capacities 
express the antibacterial activity of LLE ointment against S. aureus and S. epidermidis, meaning that 
LLE can be used as a topical antibacterial agent. 
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Herbal medicine is one type of treatments that are currently developed. In the case of infectious 
diseases, herbal remedies have become a positive aspect in the world of health, considering how, 
today, numerous types of bacteria can be immune to certain antibiotics. Accordingly, research is 
required to obtain supporting evidence and affirm the therapeutic effects of herbs. 
One of the plants that can be applied as medicine is white leadtree, locally known as petai cina 
or kemlandhingan in Indonesia, with the scientific name Leucaena leucocephala (Lam) de Wit or 
Leucaena glauca. L. leucocephala is a shrub plant originating in Mexico and has now spread to many 
countries including Indonesia. Practical experience shows that it has long been used as a medicinal 
plant, for instance, by administering its finely ground, crushed, or chewed leaves to the wound 
(Hiwale, 2015; Devi  et al., 2013; Latief, 2012). 
Several studies have shown that L. leucocephala leaf extract (LLE) possesses several chemical 
compounds. Research using Thin Layer Chromatography (TLC) has proved that the ethanol extract of 
L. leucocephala leaf contains alkaloids, flavonoids, saponins, and tannins (Suryana, 2017). Another 
study with Gas Chromatography (GC) has identified the presence of terpenes, along with squalene as a 
secondary metabolite in LLE (Awe, 2013; Mohammed et al., 2015; Negi et al., 2016). Flavonoids, 
tannins, terpenes, and triterpene are known as phytochemical substances that have antibacterial 
properties (Aderibigbe, 2011;  Mohammed et al., 2015; Negi et al., 2016; Zayed and Samling, 2016; 
Suryana, 2017). In other words, previous studies have confirmed that L. leucocephala leaf extract 
(LLE) has antibacterial properties. 
Many pathogenic bacteria can infect the human body. Among them are Staphylococcus aureus 
and Staphylococcus epidermidis that cause skin diseases, such as impetigo, rash, folliculitis, acne, and 
sepsis in the surgical wound (Otto, 2009; Elliott et al., 2013; Harti, 2015). Testing the antibacterial 
activity of an ointment containing L. leucocephala leaf extract with various concentration against these 
two bacteria is therefore necessary, particularly to determine the appropriate level of extract in LLE 
ointment to treat the resulting infections efficaciously.  
 
MATERIALS AND METHODS 
Materials dan instruments 
L. leucocephala leaf extract (LLE) was obtained from the maceration of L. leucocephala leaf 
powder taken from community plantations in Limbangan District, Kendal Regency. The maceration 
was carried out using ethanol 70% and left in a dark place while stirred occasionally for 3 x 24 hours 
(Hanani, 2014). The extract produced in this process was then made into ointment using white vaseline 
(vaselinum album) with varying concentrations, as presented in Table I. The tested bacteria, namely S. 
aureus and S. epidermidis, were acquired from the Health Laboratory Office in Central Java Province. 
These bacteria were planted in nutrient agar (Oxoid) medium, and the antibacterial activity testing of 
the LLE ointment with 0% to 100% extract concentrations was performed on them. Gentamicin 
Sulfate 0.1% ointment (generic) and Oxytetracycline ointment (generic) were used as positive 
controls. 
Meanwhile, the instruments used in this study were laboratory glassware, mortar and pestle, 




Formulation design and physical test for LLE ointment 
This study is a true experiment conducted in the laboratory using a randomized design for the 
formulation of LLE ointments with variations in the extract ratio. The composition of the ointments is 
shown in Table I. 
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Table I. The design of the LLE ointment formulation 
 
Materials  F 1 F2 F 3 F 4 F 5 F6 F 6 
L. leucocephala leaf 
extract (LLE) 
0% 5% 10% 15% 20% 25% 100% 
Vaselinum album ad 25 g 25g 25g 25g 25 g 25 g 25 g 
 
Physical test of LLE ointment 
In this study, the physical test of the prepared ointment included homogeneity and pH. The 
cream was applied on a glass object, then rubbed and touched to find out its homogeneity. The pH test 
was performed using a pH meter and universal indicator (Widyantoro and Sugihartini, 2015).  
 
Preparation of antibacterial activity assay 
The antibacterial test of LLE ointment against S. aureus and S.  epidermidis was carried out 
using the disc diffusion method (cup plate technique). The antibacterial activity was determined by 
measuring the diameter of inhibition zone―i.e., an area where bacterial growth is prevented, which 
was formed after incubation. S. aureus and S. epidermidis were poured into the nutrient agar medium. 
Then, a well was made in several places, and LLE ointment was filled into it. The medium was 
incubated at 37
0
C for 24-48 hours. After incubation, the diameter of inhibition zone was measured 
(Radji, 2010; Mathur et al., 2013). Replication was conducted five times for each formula. Gentamicin 
Sulfate 0.1% ointment and Oxytetracycline ointment were used as both comparators and positive 
controls that received the same treatment as the LLE ointment samples. 
 
RESULTS AND DISCUSSION 
The maceration  of  L. leucocephala leaf  powder  produced a thick, brownish-green extract with 
a distinctive odor. Extracts with different concentrations (0%, 5%, 10%, 15%, 20% and 25%) were 
then made into 25g ointments with six different formulas and vaselinum album as the base. The 
ointments were dark brownish green and sticky with a distinctive smell. The color of the ointment 
comes from the color of the LLE. With a greater concentration of LLE, the color of the produced 
ointment was closer to that of LLE.  
The pH test of each formula revealed a stable pH at 6 from the first to the fifth week. As for the 
homogeneity test, it showed that all formulas were homogeneous, as evidenced by their tactile quality, 
i.e., smooth feeling when touched, without any granules, and homogeneous color. 
The observations showed that the pH of the LLE ointments was 6 from the first to the fifth 
week. This pH indicates that they are safe for use and will not cause irritation on the skin. An ointment 
is considered good when its pH is similar to the pH of the human skin, which is 4.5 to 6.5. The smaller 
the pH of the preparation, the more acidic it is, and the more it irritates the skin. Meanwhile, 
preparation with higher pH or alkaline condition can make the skin drier. 
The antibacterial activity of LLE ointment against S. aureus was shown by the zone of 
inhibition in the nutrient agar medium, as presented in Figure 1. The LLE ointment started to inhibit 
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   (A)                 (B)                      (C)                       (D) 
     
   (E)          (F)         (G)        (H) 
 
Figure 1. The Antibacterial Activity of L. leucocephala Extract Ointment against S. aureus 
 (A): 5% LLE Ointment    (E): 25% LLE Ointment 
 (B): 10% LLE Ointment   (F): 100% LLE Ointment 
 (C): 15% LLE Ointment   (G): Gentamicin Ointment 0.1% 
 (D): 20% LLE Ointment   (H): Oxytetracycline Ointment 
  
 
Figure 2 shows the antibacterial activity of the LLE ointments against S. epidermidis. The zone 
of inhibition started to appear in the nutrient agar medium when the dosage forms contained at least 
25% LLE (Figure 2 E). 
 
                       
(A)                   (B)     (C)  (D) 
       
  (E)          (F)       (G)  (H) 
 
Figure 2. The Antibacterial Activity of L. leucocephala Extract Ointment Against S. epidermidis 
 (A): 5% LLE Ointment    (E): 25% LLE Ointment 
 (B): 10% LLE Ointment   (F): 100% LLE Ointment 
 (C): 15% LLE Ointment   (G): Gentamicin Ointment 0.1% 
 (D): 20% LLE Ointment   (H): Oxytetracycline Ointment 
 
The antibacterial activity was determined by measuring the diameter of the inhibition zone. The 
measurement results for the inhibition of S. aureus and S. epidermidis growth are summarized in 
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Table II. The antibacterial activity of LLE ointment against S. aureus dan S. epidermidis 
 
Samples  The diameter of the 
inhibition zone of S. aureus 
(mm) 
The diameter of the 
inhibition zone of S. 
epidermidis (mm) 
   
F1 0 0 
F2 0 0 
F3 0 0 
F4 0 0 
F5 12.70 ± 0.45 0 
F6 14.80 ± 0.27 10.60 ± 0.55 
F7 24.80 ± 0.45 22.40 ± 0.89 
K1 13.50 ± 0.71 23.80 ± 1.60 
K2 45.90 ± 0.22 16.20 ± 0.45 
 
Notes: 
 F1: 0% LLE Ointment    F6: 25% LLE Ointment 
 F2: 5% LLE Ointment                     F7: 100% LLE Ointment 
 F3: 10% LLE Ointment   K1: Gentamicin Ointment 0.1% 
 F4: 15% LLE Ointment   K2: Oxytetracycline ointment 
 F5: 20% LLE Ointment 
 
The results showed that the LLE exhibited antibacterial activity against S. aureus and S.  
epidermidis. It is indicated by the increasing diameter of the zone of inhibition as the concentration of 
LLE in the ointment increases. In other words, increasing the proportion of LLE in the ointment is 




Figure 3. Graph of Diameter Inhibition Zone of S. aureus and S. epidermidis Growth 
 by Antibacterial Activities of L. leucocephala Extract Ointments 
 
Figure 3 shows that starting at a concentration of 20%, LLE ointment can stop the growth of S. 
aureus bacteria with a zone diameter of 12.70 ± 0.45 mm. This inhibition intensifies with an increase 
in LLE content. At a concentration of 25%, LLE ointment has a more significant inhibitory effect than 
Gentamicin ointment. The analysis of variance (ANOVA) produced Fount > Ftable (Fcount= 4811.293, 
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Ftable= 2.87), indicating differences in antibacterial activity between groups. The ANOVA was 
followed by a post hoc test (Bonferroni), which revealed that the antibacterial effect of 20% LLE 
ointment was not significantly different from Gentamicin ointment (p-value= 0.112> 0.05). Compared 
with Oxytetracycline ointment, the LLE cream results in lower bacterial growth inhibition. 
The figure also depicts that the growth of S. epidermidis is inhibited by LLE ointment that has at least 
25% extract concentration. In other words, below that level, the ointment cannot stop the growth of S. 
epidermidis. In pure LLE (100%; F7), the bacterial growth inhibition is close to the antibacterial 
activity of Gentamicin ointment. The ANOVA on F6, F7, K1, and K2 produced Fcount > Ftable (Fcount= 
184.583, Ftable= 3.24), implying a statistically significant difference between the antibacterial activities 
of the concentration groups. The ANOVA was followed by a post hoc test (Bonferroni), which showed 
that the antibacterial effect of pure L. leucocephala leaf extract was not significantly different from 
Gentamycin sulfate 0.1% ointment (p-value = 0.250> 0.05). Compared with Oxytetracycline, the LLE 
ointment produces a lower bacterial growth inhibition. 
The antibacterial activity of LLE ointment is caused by the ethanol extract of L. leucocephala leaf that 
contains secondary metabolites. Previous research has found that LLE comprises flavonoids, tannins, 
and saponins that have antibacterial properties (Suryana et al., 2017). Also, it possesses phytol 
(terpene compounds) and squalene (triterpene compounds), which are efficacious as antibacterial 
(Zayed and Samling, 2016; Suryana et al., 2017). This study has proved that LLE ointment with a 
minimum concentration of 20% and 25% can be used as an alternative topical treatment for the 
infection of S. aureus and S. epidermidis, respectively. 
 
CONCLUSION 
L. leucocephala leaf extract ointment has antibacterial activity against S. aureus and S. 
epidermidis when prepared with extract concentrations of at least 20% and 25%, respectively. A 
further study is recommended to include testing on the antibacterial activity of LLE ointment against 
other types of bacteria and in different dosage forms and the ability of ointments in wound healing. 
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